Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03917849
Other study ID # UCordoba
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2, 2018
Est. completion date March 22, 2020

Study information

Verified date July 2020
Source Universidad Nacional de Córdoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this project is to investigate the efficacy of Inertial Flywheel Resistance program vs Heavy slow resistance in patients with chronic patellar tendinopathy.

The investigators hypothesize that Inertial Flywheel Resistance program will yield a more positive clinical outcome and function in patients with patellar tendinopathy compared to heavy slow resistance group.


Description:

Randomized controlled intervention study


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date March 22, 2020
Est. primary completion date March 22, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of patellar tendinopathy

- Symptoms > 3 months

- Pain localized to the inferior pole of the patella

- Victorian Institute of Sport Assessment (VISA) score less than 80 points

- Palpation tenderness of the patellar tendon

- Abnormal tendon (hypoechoic) confirmed by ultrasonography.

Exclusion Criteria:

- Previous knee surgery

- Confounding diagnosis to the knee joint

- Previous corticosteroids injections

- Arthritis or diabetes

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercises program for patellar tendinopathy
To compare the effectiveness of the inertial flywheel resistance program versus slow heavy resistance in patients with chronic patellar tendinopathy

Locations

Country Name City State
Argentina Universidad Nacional de Cordoba Cordoba
Argentina Universidad Nacional de Cordoba Córdoba C

Sponsors (1)

Lead Sponsor Collaborator
Universidad Nacional de Córdoba

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Victorian Institute of Sports Assessment (VISA-P questionnaire) Self-administered questionnaire. Consists of 8 items; 6 are used to evaluate pain levels or disability in daily activities and specific functional tests and 2 provide information regarding ability to play sport. Response options for each item are provided on a numeric rating scale (from 0 to 10), with higher scores indicating lower levels of pain or disability for all items other than 7 and 8, for which options have weighted scores. 0 - 12 weeks
Secondary Patient-Specific Functional Scale Self-reported patient-specific outcome measure assess functional change, primarily in patients presenting with musculoskeletal disorders. Patients are asked to identify up to 3 important activities they are unable to perform or are having difficulty with as a result of their problem. In addition to identifying the activities, patients are asked to rate, on an 11-point scale, the current level of difficulty associated with each activity. Following the intervention, patients are asked again to rate the activities previously identified. 0 - 12 weeks
Secondary Patient Global Impression of Change Register patient's belief about the efficacy of treatment. PGIC is a 7 point scale depicting a patient's rating of overall improvement. Patients rate their change as "very much improved," "much improved," "minimally improved," "no change," "minimally worse," "much worse," or "very much worse." 12 weeks
Secondary Adverse events To capture all adverse events and side effects that occurred after exercises protocol. Patients reported any changes or any symptoms. If a question was answered "yes", we asked for further comments. 12 weeks
Secondary Adherence self-report questionnaire Patients were asked to choose one of six descriptions (from level 1 = perfect adherence to level 6 = nonadherence) to express exercise treatment at the end of the twelve weeks study period. 12 weeks
Secondary Single-leg decline squat (SLDS) test A reliable patellar tendon pain provocation test, will be used to assess pain. Pain is rated on an 11-point numeric rating scale, where 0 is no pain and 10 is the worst pain imaginable. 0 - 12 weeks
Secondary Knee extension machine test A reliable patellar tendon pain provocation test, will be used to assess pain. Pain is rated on an 11-point numeric rating scale, where 0 is no pain and 10 is the worst pain imaginable. 0 - 12 weeks
Secondary Jump test Counter movement Jump and Triple hop for distance will be used to assess patellar tendinopathy caused functional deficits on the injured site compared with the non-injured site. The distance is measured in centimeters. 0 - 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05423366 - Comparative Effects of Focused and Unfocused (Radial) ESWT in the Treatment of Patellar Tendinopathy. N/A
Completed NCT04153877 - The Effect of Kinesio-tape® on Pain and Vertical Jump Performance in Active Individuals With Patellar Tendinopathy
Completed NCT04339569 - Landing Biomechanics Following Fatigue in Athletes With and Without a History of Patellar Tendinopathy
Completed NCT03694730 - Continued Activity During Rehabilitation in Patients With Patellar Tendinopathy N/A
Completed NCT03528746 - The Acute Effect of Isometric Versus Isotonic Resistance Exercise in Patients With Patellar Tendinopathy N/A
Active, not recruiting NCT04753853 - Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy N/A
Active, not recruiting NCT05538494 - Effects on the Patellar Tendon After Low-load Blood Flow Restriction Training. N/A
Completed NCT04219917 - A Comparison of Kinesio® Taping Methods for Subjects With Patellar Tendonitis N/A
Completed NCT04682496 - Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy N/A
Completed NCT03136965 - Platelet-Rich Plasma Therapy for Patellar Tendinopathy Phase 2